Targeted Molecular Therapies in the Treatment of Esophageal Adenocarcinoma, Are We There Yet?

SIMPLE SUMMARY: Traditional therapeutic approaches to esophageal adenocarcinoma involve a combination of surgery, chemotherapy, and radiation. Despite innovations in treatment, outcomes remain poor. Targeted molecular therapies and immunotherapies have been used to great effect in various other soli...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalafi, Shayan, Lockhart, Albert Craig, Livingstone, Alan S., El-Rifai, Wael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690268/
https://www.ncbi.nlm.nih.gov/pubmed/33105560
http://dx.doi.org/10.3390/cancers12113077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690268/
https://www.ncbi.nlm.nih.gov/pubmed/33105560
http://dx.doi.org/10.3390/cancers12113077

Ejemplares similares